Clinical data | |
---|---|
Trade names | Nibal Injection, Primobolan Depot |
Synonyms | Methenolone enanthate; Metenolone heptanoate; NSC-64967; SH-601; SQ-16374 |
Routes of administration |
Intramuscular injection |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Biological half-life | IM: 4–5 days |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.005.584 |
Chemical and physical data | |
Formula | C27H42O3 |
Molar mass | 414.621 g/mol |
3D model (JSmol) | |
|
|
|
|
(what is this?) |
Metenolone enanthate (brand names Nibal Injection, Primobolan Depot), or methenolone enanthate, is an injected anabolic-androgenic steroid (AAS) of the dihydrotestosterone (DHT) group. It is a C17β ester of metenolone, and acts as a prodrug of metenolone in the body. Whereas metenolone enanthate is the form of metenolone used for intramuscular injection, metenolone acetate is the form used for oral administration.
As a derivative of DHT, metenolone, the active form of metenolone enanthate, is not aromatized, and so has no propensity for producing estrogenic side effects like gynecomastia. As an AAS, metenolone enanthate is antigonadotropic and can suppress the hypothalamic-pituitary-gonadal axis and reversible hypogonadism and infertility.
Metenolone enanthate, also known as metenolone 17β-enanthate, is a synthetic androstane steroid and a derivative of DHT. It is the C17β ester metenolone, which itself is 1-methyl-δ1-4,5α-dihydrotestosterone (1-methyl-δ1-DHT) or 1-methyl-5α-androst-1-en-17β-ol-3-one.
Methenolone enanthate is the USAN of metenolone enanthate, and methenolone is the BAN of its active form, metenolone. Conversely, metenolone is the INN of metenolone.